Jesse D. Krebs v. HHS - Influenza, transverse myelitis (2024)
Case summary [AI summaries can sometimes make mistakes]
Jesse D. Krebs filed a petition for compensation alleging that he suffered from transverse myelitis as a result of an influenza vaccine administered on October 16, 2019.
The petition was filed on October 13, 2020. Respondent initially asserted that the case was not appropriate for compensation.
The parties engaged in settlement discussions for an extended period, involving life care planners and economists. On April 2, 2024, they indicated a desire to resume litigation.
On October 12, 2023, Jesse D. Krebs filed a motion for interim attorneys' fees and costs.
Respondent deferred to the special master's determination but stated satisfaction with the statutory requirements for an award. The Special Master found that the petition was brought in good faith with a reasonable basis, and that an interim award was appropriate due to the protracted nature of the proceedings and accumulated fees and costs.
The Special Master awarded $69,703.35 in interim attorneys' fees and costs, jointly payable to the petitioner and his counsel, John Scanlon.
Source PDFs
USCOURTS-cofc-1_20-vv-01374